Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Testa

Showing results (171-180 of 305) with videos related to

Pageof 31
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2017
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)Luca Testa, Marco De Carlo, Alessandro Petrolini, et al.
Circulation|February 28, 2013
Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving SystemLuca Testa, Azeem Latib, Federico De Marco, et al.
International Journal of Cardiology|January 21, 2017
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry)Cosmo Godino, Mauro Chiarito, Michael Donahue, et al.
Journal of the American Heart Association|September 29, 2022
Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney DiseaseGabriele Crimi, Vincenzo De Marzo, Federico De Marco, et al.
JACC. Cardiovascular Interventions|April 7, 2018
Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry ResultsStephen G Ellis, Tommaso Gori, Patrick W Serruys, et al.
Frontiers in Cardiovascular Medicine|January 30, 2023
Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative projectLuca Testa, Antonio Popolo Rubbio, Mattia Squillace, et al.
JACC. Cardiovascular Interventions|March 12, 2016
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS TrialSara Ariotti, Marianna Adamo, Francesco Costa, et al.
American Heart Journal|November 2, 2013
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates studyMarco Valgimigli, Athanasios Patialiakas, Attila Thury, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 1, 2024
Transcatheter aortic valve replacement with corevalve self-expanding bioprosthesis: Clinical and durability data up to 12 yearsLuca Testa, Cristina Giannini, Giulia Costa, et al.
International Journal of Cardiology|April 10, 2016
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry)Antonio Colombo, Cosmo Godino, Michael Donahue, et al.
Pageof 31

Showing results (171-180 of 305) with videos related to

Sort By:
Pageof 31
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2017
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)Luca Testa, Marco De Carlo, Alessandro Petrolini, et al.
Circulation|February 28, 2013
Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving SystemLuca Testa, Azeem Latib, Federico De Marco, et al.
International Journal of Cardiology|January 21, 2017
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry)Cosmo Godino, Mauro Chiarito, Michael Donahue, et al.
Journal of the American Heart Association|September 29, 2022
Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney DiseaseGabriele Crimi, Vincenzo De Marzo, Federico De Marco, et al.
JACC. Cardiovascular Interventions|April 7, 2018
Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry ResultsStephen G Ellis, Tommaso Gori, Patrick W Serruys, et al.
Frontiers in Cardiovascular Medicine|January 30, 2023
Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative projectLuca Testa, Antonio Popolo Rubbio, Mattia Squillace, et al.
JACC. Cardiovascular Interventions|March 12, 2016
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS TrialSara Ariotti, Marianna Adamo, Francesco Costa, et al.
American Heart Journal|November 2, 2013
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates studyMarco Valgimigli, Athanasios Patialiakas, Attila Thury, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 1, 2024
Transcatheter aortic valve replacement with corevalve self-expanding bioprosthesis: Clinical and durability data up to 12 yearsLuca Testa, Cristina Giannini, Giulia Costa, et al.
International Journal of Cardiology|April 10, 2016
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry)Antonio Colombo, Cosmo Godino, Michael Donahue, et al.
Pageof 31